Cargando…

PET imaging and treatment of pancreatic cancer peritoneal carcinomatosis after subcutaneous intratumoral administration of a novel oncolytic virus, CF33-hNIS-antiPDL1

Peritoneal carcinomatosis of gastrointestinal malignancies remains fatal. CF33-hNIS-antiPDL1, a chimeric orthopoxvirus expressing the human sodium iodide symporter (hNIS) and anti-human programmed death-ligand 1 antibody, has demonstrated robust preclinical activity against pancreatic adenocarcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhifang, Yang, Annie, Chaurasiya, Shyambabu, Park, Anthony K., Kim, Sang-In, Lu, Jianming, Olafsen, Tove, Warner, Susanne G., Fong, Yuman, Woo, Yanghee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784298/ https://www.ncbi.nlm.nih.gov/pubmed/35118191 http://dx.doi.org/10.1016/j.omto.2021.12.022

Ejemplares similares

Anti-Tumor Immunogenicity of the Oncolytic Virus CF33-hNIS-antiPDL1 against Ex Vivo Peritoneal Cells from Gastric Cancer Patients
por: Zhang, Zhifang, et al.
Publicado: (2023)

A comprehensive preclinical study supporting clinical trial of oncolytic chimeric poxvirus CF33-hNIS-anti-PD-L1 to treat breast cancer
por: Chaurasiya, Shyambabu, et al.
Publicado: (2021)

An Oncolytic Poxvirus Encoding hNIS, Shows Antitumor Efficacy and Allows Tumor Imaging in a Liver Cancer Model
por: Chaurasiya, Shyambabu, et al.
Publicado: (2023)

Oncolytic poxvirus CF33-hNIS-ΔF14.5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer model
por: Chaurasiya, Shyambabu, et al.
Publicado: (2020)

A Novel Chimeric Poxvirus Encoding hNIS Is Tumor-Tropic, Imageable, and Synergistic with Radioiodine to Sustain Colon Cancer Regression
por: Warner, Susanne G., et al.
Publicado: (2019)

Peritoneal-directed chimeric oncolytic virus CF17 prevents malignant ascites and improves survival in gastric cancer peritoneal metastases
por: Yang, Annie, et al.
Publicado: (2023)

CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study
por: Yuan, Yuan, et al.
Publicado: (2023)

Development of the oncolytic virus, CF33, and its derivatives for peritoneal-directed treatment of gastric cancer peritoneal metastases
por: Yang, Annie, et al.
Publicado: (2023)

Toward comprehensive imaging of oncolytic viroimmunotherapy
por: Chaurasiya, Shyambabu, et al.
Publicado: (2021)

Oncolytic Virotherapy for Cancer: Clinical Experience
por: Chaurasiya, Shyambabu, et al.
Publicado: (2021)

SPECT/CT Imaging of hNIS -Expression after Intravenous Delivery of an Oncolytic Adenovirus and (131)I
por: Rajecki, Maria, et al.
Publicado: (2012)

Optimizing Oncolytic Viral Design to Enhance Antitumor Efficacy: Progress and Challenges
por: Chaurasiya, Shyambabu, et al.
Publicado: (2020)

Vitamin D as a Primer for Oncolytic Viral Therapy in Colon Cancer Models
por: Kim, Sang-In, et al.
Publicado: (2020)

A Novel Oncolytic Chimeric Orthopoxvirus Encoding Luciferase Enables Real-Time View of Colorectal Cancer Cell Infection
por: O’Leary, Michael P., et al.
Publicado: (2018)

Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose
por: O’Leary, Michael P., et al.
Publicado: (2018)

Fluorescent imaging for cancer therapy and cancer gene therapy
por: Woo, Yanghee, et al.
Publicado: (2021)

Oncolytic Virotherapy versus Cancer Stem Cells: A Review of Approaches and Mechanisms
por: Chaurasiya, Shyambabu, et al.
Publicado: (2018)

A chimeric poxvirus with J2R (thymidine kinase) deletion shows safety and anti-tumor activity in lung cancer models
por: Chaurasiya, Shyambabu, et al.
Publicado: (2019)

Codon-optimized Human Sodium Iodide Symporter (opt-hNIS) as a Sensitive Reporter and Efficient Therapeutic Gene
por: Kim, Young-Hwa, et al.
Publicado: (2015)

Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancer
por: Kim, Sang-In, et al.
Publicado: (2022)

hTPO和hNIS共转染肺癌细胞系H460介导放射性碘摄取的研究
Publicado: (2010)

The use of the NIS reporter gene for optimizing oncolytic virotherapy
por: Miller, Amber, et al.
Publicado: (2016)

Viroimmunotherapy for Colorectal Cancer: Clinical Studies
por: Chaurasiya, Shyambabu, et al.
Publicado: (2017)

In vitro study on human umbilical cord mesenchymal stem cells transfected with lentivirus-mediated hNIS-EGFP dual reporter gene and co-labeled with superparamagnetic iron oxide
por: Meng, Yu, et al.
Publicado: (2018)

Oncolytic Herpes Simplex Virus Prevents Premalignant Lesions from Progressing to Cancer
por: Woo, Yanghee, et al.
Publicado: (2019)

The Oncolytic Activity of Myxoma Virus against Soft Tissue Sarcoma Is Mediated by the Overexpression of Ribonucleotide Reductase
por: Woo, Yanghee, et al.
Publicado: (2021)

2-Aminopurine Enhances the Oncolytic Activity of an E1b-Deleted Adenovirus in Hepatocellular Carcinoma Cells
por: Sharon, David, et al.
Publicado: (2013)

The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131
por: Choi, Yun, et al.
Publicado: (2013)

Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma
por: Chen, Steven F., et al.
Publicado: (2018)

Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics
por: Goto, Yamato, et al.
Publicado: (2023)

Dual-Isotope SPECT Imaging with NIS Reporter Gene and Duramycin to Visualize Tumor Susceptibility to Oncolytic Virus Infection
por: Zhang, Lianwen, et al.
Publicado: (2019)

Comparison of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a murin model of peritoneal carcinomatosis
por: Facy, Olivier, et al.
Publicado: (2011)

Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy
por: Yin, Jie, et al.
Publicado: (2017)

Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds
por: Sivanandam, Venkatesh, et al.
Publicado: (2019)

Managing NFS and NIS /
por: Stern, Hal
Publicado: (1992)

Managing NFS and NIS
por: Eisler, Mike, et al.
Publicado: (2001)

Molecular imaging of oncolytic viral therapy
por: Haddad, Dana, et al.
Publicado: (2015)

Synthesis of Novel Peptide Dendrimers PDL-GB2 and PDL-G2
por: Yunzhu, Lin, et al.
Publicado: (2015)

HSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapy
por: Li, H, et al.
Publicado: (2013)

Non-Enzymatic Glucose Detection Based on NiS Nanoclusters@NiS Nanosphere in Human Serum and Urine
por: Arivazhagan, Mani, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o10818mkjat6b6t88b07t0i4sh